購(gòu)物車(chē) 
-
普沙托韋
- names：
Presatovir
- CAS號(hào)：
1353625-73-6
MDL Number： No data available - MF(分子式)： C24H30ClN7O3S MW(分子量)： 532.06
- EINECS:No data available Reaxys Number:No data available
- Pubchem ID:58029842 Brand:BIOFOUNT
普沙托韋(1353625-73-6,Presatovir)是人類(lèi)呼吸道合胞病毒（RSV）融合蛋白（F蛋白）抑制劑，普沙托韋具有潛在的抗病毒活性。普沙托韋與病毒表面的F蛋白特異性結(jié)合，從而抑制RSV F蛋白介導(dǎo)的與宿主細(xì)胞膜的融合并阻止病毒進(jìn)入。
| 貨品編碼 | 規(guī)格 | 純度 | 價(jià)格 (￥) | 現(xiàn)價(jià)(￥) | 特價(jià)(￥) | 庫(kù)存描述 | 數(shù)量 | 總計(jì) (￥) |
|---|---|---|---|---|---|---|---|---|
| YZM000866-10mg | 10mg | 99.9% | ￥ 6076.00 | ￥ 6076.00 | 2-3天 | ￥ 0.00 | ||
| YZM000866-5mg | 5mg | 99.9% | ￥ 3412.00 | ￥ 3412.00 | 2-3天 | ￥ 0.00 |
- 大包裝詢(xún)價(jià) 提供各種包裝，敬請(qǐng)垂詢(xún)
- 收藏商品 商品點(diǎn)評(píng) 加入購(gòu)物車(chē) 立即購(gòu)買(mǎi)
| 中文別名 | 普沙托韋(1353625-73-6,Presatovir);GS-5806 |
| 英文別名 | Presatovir(1353625-73-6,GS-5806) |
| CAS號(hào) | 1353625-73-6 |
| Inchi | InChI=1S/C24H30ClN7O3S/c1-15-13-32-22(27-23(15)30-10-8-17(26)14-30)12-20(28-32)21-5-3-4-9-31(21)24(33)18-11-16(25)6-7-19(18)29-36(2,34)35/h6-7,11-13,17,21,29H,3-5,8-10,14,26H2,1-2H3/t17-,21-/m0/s1 |
| InchiKey | GOFXWTVKPWJNGD-UWJYYQICSA-N |
| 分子式 Formula | C24H30ClN7O3S |
| 分子量 Molecular Weight | 532.06 |
| 溶解度Solubility | DMSO >15 mg/ml |
| 性狀 | 灰白色至淺黃色固體粉末 |
| 儲(chǔ)藏條件 Storage conditions | -20°C 3 years年 4°C 2 years年 / 溶液中:-80°C 6 months月 -20°C 1 month月 |
普沙托韋(1353625-73-6,Presatovir)實(shí)驗(yàn)注意事項(xiàng)：
1.實(shí)驗(yàn)前需戴好防護(hù)眼鏡，穿戴防護(hù)服和口罩，佩戴手套，避免與皮膚接觸。
2.實(shí)驗(yàn)過(guò)程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生，必要時(shí)實(shí)驗(yàn)操作需要手套箱內(nèi)完成以免對(duì)實(shí)驗(yàn)人員造成傷害
3.實(shí)驗(yàn)后產(chǎn)生的廢棄物需分類(lèi)存儲(chǔ)，并交于專(zhuān)業(yè)生物廢氣物處理公司處理，以免造成環(huán)境污染
Presatovir(1353625-73-6,GS-5806) Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
Tag:普沙托韋(1353625-73-6,Presatovir),普沙托韋試劑,普沙托韋抑制劑,普沙托韋的純度,普沙托韋雜質(zhì),普沙托韋的含量,普沙托韋的作用,普沙托韋的使用,普沙托韋的外觀,普沙托韋的溶解度,普沙托韋的合成,普沙托韋的生產(chǎn),普沙托韋的性質(zhì)
| 產(chǎn)品說(shuō)明 | 普沙托韋(1353625-73-6,Presatovir)是人類(lèi)呼吸道合胞病毒（RSV）融合蛋白（F蛋白）抑制劑，普沙托韋具有潛在的抗病毒活性。 |
| Introduction | Presatovir(1353625-73-6,普沙托韋) is an orally available inhibitor of human respiratory syncytial virus (RSV) fusion protein (F protein), with potential antiviral activity. |
| Application1 | 普沙托韋(1353625-73-6,Presatovir)可以通過(guò)阻斷病毒細(xì)胞融合過(guò)程來(lái)抑制多種呼吸道合胞病毒臨床分離株。 |
| Application2 | 普沙托韋(1353625-73-6,Presatovir)也可以抑制融合前或融合后呼吸道合胞病毒的構(gòu)象變化 |
| Application3 | Presatovir has been used in trials studying the treatment of RSV Infection, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections, and Respiratory Syncytial Virus (RSV) Infections. |
| 警示圖 | |
| 危險(xiǎn)性 | warning |
| 危險(xiǎn)性警示 | Not available |
| 安全聲明 | H303吞入可能有害+H313皮膚接觸可能有害+H2413吸入可能對(duì)身體有害 |
| 安全防護(hù) | P264處理后徹底清洗+P280戴防護(hù)手套/穿防護(hù)服/戴防護(hù)眼罩/戴防護(hù)面具+P305如果進(jìn)入眼睛+P351用水小心沖洗幾分鐘+P338取出隱形眼鏡（如果有）并且易于操作,繼續(xù)沖洗+P337如果眼睛刺激持續(xù)+P2393獲得醫(yī)療建議/護(hù)理 |
| 備注 | 實(shí)驗(yàn)過(guò)程中防止吸入、食入，做好安全防護(hù) |
| Impact of Respiratory Virus Infections in Exacerbation of Acute and Chronic Rhinosinusitis(Current Allergy and Asthma Reports,2017) |
| Antiviral Consideration for Transplantation Including Drug Resistance(Principles and Practice of Transplant Infectious Diseases,2019) |
| Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020 |
| The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Oral Session(Bone Marrow Transplantation,2018) |
| Respiratory Viral Infections in Transplant Recipients(Principles and Practice of Transplant Infectious Diseases,2019) |
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study
Abstract:GS-5806 is a novel, orally bioavailable RSV fusion inhibitor discovered following a lead optimization campaign on a screening hit. The oral absorption properties were optimized by converting to the pyrazolo[1,5-a]-pyrimidine heterocycle, while potency, metabolic, and physicochemical properties were optimized by introducing the para-chloro and aminopyrrolidine groups. A mean EC50 = 0.43 nM was found toward a panel of 75 RSV A and B clinical isolates and dose-dependent antiviral efficacy in the cotton rat model of RSV infection. Oral bioavailability in preclinical species ranged from 46 to 100%, with evidence of efficient penetration into lung tissue. In healthy human volunteers experimentally infected with RSV, a potent antiviral effect was observed with a mean 4.2 log10 reduction in peak viral load and a significant reduction in disease severity compared to placebo. In conclusion, a potent, once daily, oral RSV fusion inhibitor with the potential to treat RSV infection in infants and adults is reported.
GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein
Abstract:GS-5806 is a small-molecule inhibitor of human respiratory syncytial virus fusion protein-mediated viral entry. During viral entry, the fusion protein undergoes major conformational changes, resulting in fusion of the viral envelope with the host cell membrane. This process is reproduced in vitro using a purified, truncated respiratory syncytial virus (RSV) fusion protein. GS-5806 blocked these conformational changes, suggesting a possible mechanism for antiviral activity.
對(duì)不起，暫無(wú)產(chǎn)品評(píng)價(jià)！
MSDS
SDS 1.0 中文
展開(kāi)
SDS 1.0 英文
展開(kāi)
- 相關(guān)產(chǎn)品
-
< >
- 推薦產(chǎn)品
-
< >
- 最新產(chǎn)品
-
< >
新聞
胞爬片免疫組化染色.png)
怎么做細(xì)胞爬片免疫組化染色實(shí)驗(yàn)
細(xì)胞爬片免疫組化染色，是通過(guò)細(xì)胞爬片是讓玻片浸在細(xì)胞培養(yǎng)基內(nèi)，細(xì)胞在玻片上生長(zhǎng)，主要用于組織學(xué)，免疫組織化學(xué)...
2020/7/20 22:04:33
提取病毒RNA的實(shí)驗(yàn)方法
提取病毒RNA方法分別有：異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26
胞插件.png)
細(xì)胞培養(yǎng)耗材技術(shù)領(lǐng)先性
細(xì)胞培養(yǎng)板行業(yè)面臨的核心痛點(diǎn)是：常規(guī)TC處理后表面親水角隨時(shí)間衰減，影響長(zhǎng)期培養(yǎng)穩(wěn)定性，BIOFOUNT高分...
2026/4/28 15:12:51
胞培養(yǎng)板.jpg)
細(xì)胞培養(yǎng)耗材關(guān)鍵性能
細(xì)胞培養(yǎng)板的水接觸角作為表面潤(rùn)濕性的核心指標(biāo)，直接影響細(xì)胞貼壁、增殖、分化及功能表達(dá)，其中40°（低接觸角/...
2026/4/28 14:52:44
脂.png)
chelex 100樹(shù)脂國(guó)產(chǎn)替代之路-BIOFOUNT范德生物
Chelex 100螯合離子交換樹(shù)脂對(duì)銅、鐵和其他重金屬?的偏好顯著高于對(duì)鈉、鉀等一價(jià)陽(yáng)離子的偏好。它對(duì)二價(jià)...
2025/11/4 14:22:46
9月開(kāi)學(xué)季——助研新學(xué)期 范德送好禮
2025/8/28 15:30:55
Waxfilm 實(shí)驗(yàn)室封口膜：技術(shù)與國(guó)際市場(chǎng)的雙重突破
在實(shí)驗(yàn)室耗材領(lǐng)域，封口膜是保障實(shí)驗(yàn)準(zhǔn)確性與穩(wěn)定性的關(guān)鍵產(chǎn)品之一。近年來(lái)，Waxfilm?實(shí)驗(yàn)室封口膜憑借其卓...
2025/5/13 13:03:40
Waxfilm實(shí)驗(yàn)室封口膜的5大突破
Waxfilm實(shí)驗(yàn)室封口膜作為生物功能膜領(lǐng)域的國(guó)產(chǎn)技術(shù)突破和品牌突破，是生物領(lǐng)域中國(guó)技術(shù)發(fā)展的縮影。
2025/5/6 17:02:07
各種微流控芯片鍵合方法的優(yōu)缺點(diǎn)
微流控芯片鍵合：目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接，每種方法都有各自的優(yōu)缺點(diǎn)。本文主要介紹聚酯...
2023/7/28 10:43:09
材料.jpg)
新一代微流控鍵合解決方案
微流控鍵合解決方案：微流控芯片制造的一個(gè)重要環(huán)節(jié)，也是最容易被忽視的--芯片鍵合。其中一個(gè)重要因素是：微流控...
2023/7/27 12:44:28
